Barclays raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $92.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Medtronic, Inc. (MDT) PT Raised to $94 at BMO Capital on 4Q Beat; 'Strength Across Franchises'May 26, 2017 10:28 AM Medtronic, Inc. (MDT) PT Raised to $93 at Oppenheimer Following 4QMay 26, 2017 9:52 AM Medtronic, Inc. (MDT) PT Raised to $86 at Morgan StanleyMay 26, 2017 7:39 AM Medtronic, Inc. (MDT) PT Raised to $95 at Cowen on 4Q Report; 'Organic Revenue Growth Trajectory Is Back on Track'May 25, 2017 5:11 PM Medtronic, Inc. (MDT) PT Raised to $91 at Stifel Following 4Q Report; 'Diversified Sales Growth & Robust Margins'May 25, 2017 3:14 PM Medtronic, Inc. (MDT) PT Raised to $91 at Evercore ISI on Strong 4Q EPS/Revenue Results; 'Gross Margin Beat Despite Mix Shift'May 25, 2017 11:28 AM Medtronic (MDT) Tops Q4 EPS by 2c; Sees FY18 Constant Currency Revenue Growth of 4-5%May 25, 2017 6:46 AM Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial ResultsMay 25, 2017 6:46 AM Medtronic (MDT) Enrolls First Patient in Study of IN.PACT AV Access Drug-Coated Balloon in Patients with ESRDMay 24, 2017 12:15 PM Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal DiseaseMay 24, 2017 12:14 PM Medtronic (MDT) May IV bid up into Q1 EPS and outlookMay 24, 2017 10:31 AM Mazor Robotics (MZOR): Takeout Unlikely Here - NeedhamMay 24, 2017 6:18 AM